Skip to main content
. Author manuscript; available in PMC: 2022 Jan 10.
Published in final edited form as: J Control Release. 2020 Oct 1;329:624–644. doi: 10.1016/j.jconrel.2020.09.055

Fig. 10.

Fig. 10.

Schematic representation of two receptor-specific peptides, Angiopep-2 and tLyP-1, mediated liposomes and their tumor-targeting delivery mechanism. Tumor penetrations and delivery of the dual peptides-modified liposomes were achieved by targeting effect of peptides as well as via the EPR effect. Anti-angiogenesis gene (VEGF siRNA) and apoptosis-inducing chemotherapy (DTX) were used as a combinational therapeutic strategy. (Reproduced with permission from [148]).